NCT04706845已完成不适用
Understanding the Burden of ACC Through the Eyes of Patients
Ayala Pharmaceuticals, Inc,1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2021年1月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
- 试验地点
- 1
- 主要终点
- Key burdens related to the disease or treatments
研究概览
简要总结
This is a comprehensive, cross-sectional study conducted with approximately 40-60 individuals affected by ACC who may know the results of molecular profiling of their tumor.
Primary Objectives:
- To identify the specific burdens faced by patients with ACC
- To compare/contrast the burdens faced by patients with ACC at different disease stages (no evident disease, metastatic disease/watchful waiting, progressive disease)
详细描述
This is a comprehensive, cross-sectional study conducted with approximately 40-60 individuals affected by ACC who may know the results of molecular profiling of their tumor.
Primary Objectives:
- To identify the specific burdens faced by patients with ACC
- To compare/contrast the burdens faced by patients with ACC at different disease stages (no evident disease, metastatic disease/watchful waiting, progressive disease)
Secondary Objectives:
- To assess QoL implication in patients living with ACC (Adenoid Cystic Carcinoma)
- To compare the burdens and QoL impacts in people living with ACC, with their tumors bearing Notch mutations or Notch Wild Type due to:
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participant must be a person diagnosed with ACC who is 18 years or older
- •For patients with metastatic disease; watchful waiting or progressive disease, participants must know the results of molecular profiling of their tumor
- •Histologically-confirmed diagnosis of ACC with written proof of disease and molecular profile of tumor provided. This can be a note showing genetic diagnosis from a relevant testing laboratory, physician consult notes, a medical record of diagnosis, or any other single piece of documentation that connects your name/the patient's name with ACC.
- •Able to read, write and understand English, Hebrew, Arabic, or Russian
- •Able to grant informed consent
- •Willing to participate in a 45-to-60-minute telephone interview, including follow up questions (if necessary)
排除标准
- •Inability to meet any of the inclusion criteria
结局指标
主要结局
Key burdens related to the disease or treatments
时间窗: Q4-2021
Life impacts of those burdens for patient/family
时间窗: Q4-2021
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Swallowing Impairments in Adults With and Without Alzheimer's DiseaseCaregiver BurdenHealthy AgingDysphagiaAlzheimer DiseaseNCT06678100Vanderbilt University Medical Center240
已完成
不适用
Incidence, Diagnosis, Management and Outcome of Acute Mesenteric IschemiaAcute Mesenteric IschemiaNCT05218863University of Tartu709
进行中（未招募）
不适用
Quality of life measures in Barrett's Oesophagus care pathwaysSpecialty: Gastroenterology, Primary sub-specialty: GastroenterologyUKCRC code/ Disease: Oral and Gastrointestinal/ Diseases of oesophagus, stomach and duodenumDigestive SystemDiseases of oesophagus, stomach and duodenumISRCTN76017289Wrightington, Wigan And Leigh NHS Foundation Trust750
已完成
不适用
Determination of capillary blood concentrations of the oral antidiabetics metformin and/or sitagliptin in dried blood spotsType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN14518136niversität Würzburg (Germany)250
已完成
不适用
The Burden of Acute Respiratory Failure in Chinese ICUs: a National Cohort StudyAcute Respiratory FailureAcute Respiratory Distress SyndromeNCT06213779Southeast University, China4,032